PJET yields 2000000.00% · JNJ yields 2.13%● Live data
📍 PJET pulled ahead of the other in Year 1
Combined, PJET + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PJET + JNJ for your $10,000?
Priority One Jets, Inc. operates as a full service aviation company that provides on demand air charter, jet charter membership cards, and aircraft sales for business aviation, leisure, and government travel. It offers jet sales and leasing services that include private jet leasing and sales, aircraft fractional ownership, and private jet acquisition pricing services; private jet services, including concierge services, private aircraft management and maintenance, private helicopter charter, flight monitoring and coordination, air cargo charter, and government travel services, as well as personal security, medical transport, and disasters evacuation services. The company also provides air cargo freight jet charters for freight forwarding; transportation of heavy and outsize pieces, construction equipment and machine parts, high value commodities and secure/point-to-point, aerospace equipment, peacekeeping support, and dangerous materials; and critical parcel delivery, secure aircraft loading and docking, and remote originations and destinations, as well as oil, automotive, and gas industry/equipment transportation. It offers charter services for various destinations that include New York City, Miami, Los Angeles, Las Vegas, London, Sydney, Bahamas, Monaco, Istanbul, and Ibiza. The company is based in New York, New York with additional locations in the Americas, Europe, and Asia.
Full PJET Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.